Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomesJune 25, 2018Immuno-oncologyImmunotherapy
KEYNOTE-427: Pembrolizumab monotherapy shows promise in accRCCJune 25, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Hints of nivolumab efficacy seen in biliary tract cancersJune 25, 2018GastroenterologyImmuno-oncologyGastrointestinal Cancer
Higher BMI tied to lower breast cancer risk in women before menopauseJune 22, 2018Breast CancerPatient & Survivor Care
Trifluridine/tipiracil improves survival of metastatic gastric cancerJune 22, 2018GastroenterologyGastrointestinal Cancer
Registry data provide evidence that Mohs surgery remains underutilizedJune 22, 2018Nonmelanoma Skin CancerMelanoma
Pembrolizumab does not surpass paclitaxel for gastric cancerJune 21, 2018Immuno-oncologyGastroenterologyGastrointestinal Cancer
Ramucirumab improves HCC survival after sorafenib failureJune 21, 2018GastroenterologyGastrointestinal Cancer
